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进行深入研究。因此，本课题以胃癌细胞为研究对象，采用 Western blot 法检测
虾青素刺激后氧化还原信号通路关键蛋白的激活情况，通过 DCFH-DA 法检测细
胞内 ROS 的改变，分析他们之间的相关性。结果显示，ERK5 的激活与细胞内
ROS 的量之间有一定的相关性，我们通过 PEI 法建立 ERK5 过表达细胞，采用
MTT 法检测 ERK5 对细胞增殖的影响。结果表明，ERK5 能够促进细胞增殖。 
采用 MTT 法观察细胞损伤模型的建立和虾青素的保护作用。通过显微镜下
观察细胞形态，Hoechst33342 染色观察细胞核的情况，Annexin V/PI 双染并经流
式细胞仪检测相结合的方法，研究证实AST可以有效减少 H2O2诱导的细胞凋亡。










































Astaxanthin, 3,3'-dihydroxy-β,β'-carotene-4,4'-dione, belongs to the family of 
xanthophylls. Astaxanthin has considerably potential and promising applications in 
human health and nutrition,and has been attributed with extraordinary potential for 
protecting the organism against a wide range of diseases. Most signiﬁcant activities of 
astaxanthin including its antioxidative, anticancer, antidiabetic, and anti- inﬂammatory 
properties, its protective effects on stomach, liver, the heart and the blood vessels, the 
nervous system, the eye, the skin, and other activities.  
Above all, we noted that all of the therapeutical studies of astaxanthin on gastric 
ulcer, mentioning the ability of the regulation of antioxidant enzymes, but dosen’t 
make further explanation about the molecular mechanism. Therefore, human gastric 
carcinoma cell line MGC-803 was choosen to study the antioxidant effect of 
astaxanthin. Western blot was performed to test the key proteins of some redox- 
signalings followed by astaxanthin treatment. Changes of intracellular ROS were 
detected through the DCFH-DA method, then the correlationship were analysised 
between them. It was found that activation of ERK5 is involved with the generation of 
ROS in MGC-803 cells. ERK5 overexpression cells were established by PEI assay, 
then MTT assay was used to exam the effect of ERK5 on cell proliferation. The 
results show that ERK5 can promote cell proliferation.  
We hypothesized that ERK5 is involved in the protect progress of cell damage 
caused by H2O2. First of all, cell damage model and protect effect were tested by 
MTT assay and inverted microscope observation.  We combined Hoechst33342 
staining and Annexin-V/PI staining assays to investigate whether astaxanthin could  
protect cells from apoptosis induced by H2O2 . By use of fluorescent microscopy and 
flow cytometry respectively, we were happy to find that AST cound protect cells from 
oxidant damage. Finally, we tested the cells ROS level and the changes of the ERK5 
activation. Results showed that ERK5 is important in the antioxidant activity of 
astaxanthin. 
On the other hand，like other carotenoids，bioavailability of astaxanthin is also 
depends on its structure; insolublity in water and poor stability of astaxanthin limit its 














solvent evaporation method. Single factor analysis was used to optimize the 
preparation technology, the resulting nanoparticles were well dispersible in water and 
with a mean particle size of 7.8nm. HPLC analysis method of astaxanthin was 
established, and transmission electron microscopy was used to observe the 
microstructure of the nanosized particles. Preliminary examed the stability of AST 
nanoparticles after stored at 4℃ for 3 months. Cellular uptake of AST in MGC-803 
cells was tested and activation of ERK5 was also examed by western blot. All of the 
results show that astaxanthin nanodispersions effectively improved the water 
solubility of AST, and the chemical stability was very good during the time period of 
the experiment. 
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